News and features
Read the latest news and features about our world-leading research, discoveries, fundraising and philanthropy. If you want to keep updated on our news, you can follow us on social media or sign up for our Search newsletter.
If you’re a journalist and want to find out more, you can contact our media relations team.
Doubt over high-pressure oxygen for radiotherapy-induced gastrointestinal symptoms
Patients with chronic gastrointestinal complaints caused by pelvic radiotherapy may not benefit from the standard high-pressure oxygen therapy that has been used for decades, a study has suggested.
MRI technique offers painless follow-up for prostate cancer patients
Specialised MRI could be an alternative to biopsies when deciding if prostate cancer patients should receive treatment or continue with surveillance.
Dose-finding studies for some targeted drugs need to be refined
Early clinical trials of some targeted cancer drugs may underestimate their toxicity, according to a new analysis.
Biggest database for cancer drug discovery goes 3D
The world’s largest database for cancer drug discovery has been revolutionised by adding 3D structures of faulty proteins and maps of cancer’s communication networks, according to new research.
A quarter of common brain cancer risk comes from inherited genetic faults
Around 25 per cent of the risk of developing the most common type of brain cancer, known as glioma, comes from inherited DNA errors, new research shows.
Mapping cancer’s ‘social networks’ opens new approaches to treatment
Scientists design a computer model that applies techniques used to analyse social networks to identify new ways of treating cancer.
T-VEC becomes first viral immunotherapy approved in Europe
A viral immunotherapy for cancer has become the first of its kind to be approved by the European Medicines Agency for use in adults with advanced melanoma.
Scientists discover how tumours hijack body’s wound healing process
Scientists have discovered how cells that usually help repair wounds can switch from friend to foe, escalating tumour growth and cancer spread.
ICR recognised as a top spot for pharmacology and drug discovery in the UK
The ICR wins a Pharmacology On The Map award from the British Pharmacological Society, to recognise our contribution to improving human health.
Local protein factories make cancer cells motile
Making key proteins at the driving edge of cancer cells is crucial for the spread of the disease around the body, new research concludes.
NICE makes decisions on use of three innovative cancer drugs on NHS: ICR statement
ICR CEO Professor Paul Workman comments on decisions by NICE today to recommend the drugs olaparib and enzalutamide for use on the NHS, but reject the ICR-discovered prostate cancer drug abiraterone.
ICR wins prestigious award for openness in animal research communication
The ICR has won a prestigious communications award that celebrates our success in communicating openly about animal research.
